Jacobs Levy Equity Management’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-60,893
| Closed | -$848K | – | 1044 |
|
2021
Q3 | $848K | Sell |
60,893
-27,239
| -31% | -$379K | 0.01% | 778 |
|
2021
Q2 | $1.64M | Sell |
88,132
-6,512
| -7% | -$121K | 0.01% | 639 |
|
2021
Q1 | $2.21M | Buy |
94,644
+20,965
| +28% | +$490K | 0.02% | 578 |
|
2020
Q4 | $1.38M | Buy |
73,679
+21,291
| +41% | +$398K | 0.01% | 651 |
|
2020
Q3 | $1.33M | Buy |
52,388
+20,111
| +62% | +$512K | 0.01% | 600 |
|
2020
Q2 | $932K | Sell |
32,277
-2,446
| -7% | -$70.6K | 0.01% | 681 |
|
2020
Q1 | $1.67M | Sell |
34,723
-12,057
| -26% | -$581K | 0.02% | 519 |
|
2019
Q4 | $2.66M | Buy |
46,780
+41,957
| +870% | +$2.39M | 0.03% | 494 |
|
2019
Q3 | $299K | Sell |
4,823
-18,216
| -79% | -$1.13M | ﹤0.01% | 775 |
|
2019
Q2 | $1.04M | Buy |
23,039
+6,493
| +39% | +$293K | 0.01% | 638 |
|
2019
Q1 | $1.04M | Buy |
16,546
+5,987
| +57% | +$376K | 0.02% | 652 |
|
2018
Q4 | $569K | Sell |
10,559
-750
| -7% | -$40.4K | 0.01% | 713 |
|
2018
Q3 | $1.14M | Buy |
11,309
+4,963
| +78% | +$498K | 0.02% | 628 |
|
2018
Q2 | $419K | Buy |
6,346
+184
| +3% | +$12.1K | 0.01% | 835 |
|
2018
Q1 | $308K | Buy |
6,162
+3,324
| +117% | +$166K | 0.01% | 865 |
|
2017
Q4 | $137K | Buy |
+2,838
| New | +$137K | ﹤0.01% | 939 |
|
2017
Q3 | – | Sell |
-3,563
| Closed | -$252K | – | 1003 |
|
2017
Q2 | $252K | Hold |
3,563
| – | – | 0.01% | 797 |
|
2017
Q1 | $231K | Hold |
3,563
| – | – | ﹤0.01% | 769 |
|
2016
Q4 | $335K | Sell |
3,563
-957
| -21% | -$90K | 0.01% | 748 |
|
2016
Q3 | $510K | Sell |
4,520
-150
| -3% | -$16.9K | 0.01% | 714 |
|
2016
Q2 | $381K | Buy |
+4,670
| New | +$381K | 0.01% | 828 |
|
2016
Q1 | – | Sell |
-1,990
| Closed | -$97K | – | 1160 |
|
2015
Q4 | $97K | Buy |
+1,990
| New | +$97K | ﹤0.01% | 741 |
|
2015
Q3 | – | Sell |
-3,925
| Closed | -$182K | – | 850 |
|
2015
Q2 | $182K | Buy |
+3,925
| New | +$182K | ﹤0.01% | 734 |
|